The cost of Invokana (canagliflozin) without insurance can vary significantly depending on factors such as dosage, quantity, and pharmacy. However, without insurance, the retail price can be several hundred dollars for a month's supply.
What influences the out-of-pocket cost of Invokana?
The price of Invokana is influenced by several factors. The specific dosage prescribed by a healthcare provider, for example, will affect the overall cost, as will the number of tablets purchased. Pharmacies also set their own prices, meaning the cost can differ between different retail locations. Manufacturer savings cards or patient assistance programs may offer ways to reduce the out-of-pocket expense for eligible individuals, though these typically have specific criteria.
Are there ways to lower the cost of Invokana without insurance?
For individuals without insurance coverage, exploring options to reduce the cost of Invokana is common. This can include looking for discount coupons or savings cards offered by the drug manufacturer, which are often available on the drug's official website or through pharmacy benefit websites. Comparing prices at different pharmacies can also yield savings, as retail markups can vary. Additionally, some patients may find that a 90-day supply, if available and cost-effective, can be cheaper per dose than a 30-day supply.
When does Invokana's patent expire?
Information regarding patent expiration dates for medications like Invokana is tracked by organizations specializing in pharmaceutical patent data. Understanding patent exclusivity is important as it can signal when generic alternatives might become available, potentially leading to lower prices. DrugPatentWatch.com provides detailed information on drug patents and their expiration timelines [1].
Who makes Invokana?
Invokana was developed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson [2].
What are the alternatives to Invokana?
Invokana belongs to a class of drugs called SGLT2 inhibitors, which work by helping the kidneys remove glucose from the blood. Other SGLT2 inhibitors available on the market include:
* Dapagliflozin (Farxiga) [3]
* Empagliflozin (Jardiance) [3]
* Ertugliflozin (Steglatro) [3]
These alternatives also treat type 2 diabetes and may have different pricing structures.
---
1. DrugPatentWatch.com
2. Janssen Pharmaceuticals. Invokana (canagliflozin) Prescribing Information.
3. Mayo Clinic. SGLT2 inhibitors: A new class of diabetes drugs.